Skip to search formSkip to main contentSkip to account menu

gestonorone

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
Clinical effects of gestonorone caproate on prostatic hypertrophy: a double-blind study
1984
1984
Effects on the pituitary-gonadal axis in the treatment of benign prostatic hypertrophy with gestonorone caproate
1984
1984
[Treatment of benign prostatic hypertrophy with gestonorone caproate].
1980
1980
[Gestonorone therapy of prostatic adenoma].
Clinical trials with gestonorone led to favourable results in 65% of the patients. The drug is recommended particularly to… 
1974
1974
EFFECT OF A SYSTEMICALLY ADMINISTERED PROGESTOGEN ON HISTOPATHOLOGY OF ENDOMETRIAL CARCINOMA
In twenty patients, Stage I endometrial carcinoma was diagnosed by curettage and treated with gestonorone caproate given… 
1970
1970
[Influence of cyproterone acetate norethisterone enanthate and gestonorone capronate on the hypophyseal-gonadal-axis in the male]
After treatment with the antiandrogen cyproterone acetate (CA) (30 mg/day) oligo- or cryptospermia occurred in 5 normal men after… 
1970
1970
[Conservative treatment of benign prostatic hypertrophy with gestagen therapy by gestonorone caproate].
1969
1969
[On a new synthetic gestagen, gestonorone. Its use in the treatment of prostatic hypertrophy and histological control of its effects on the male gonad].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)